Xu lab: Difference between revisions
From OpenWetWare
Jump to navigationJump to search
Peisheng Xu (talk | contribs) No edit summary |
Peisheng Xu (talk | contribs) (→News) |
||
Line 8: | Line 8: | ||
== News== | == News== | ||
* Congratulations to Dr. Xu! He receives the '''American Cancer Society Institutional Research Grant (ACS-IRG)''' from The University of South Carolina South Carolina College of Pharmacy. (02/19/13) | |||
*"'''A DNA prime-protein boost vaccination strategy targeting turkey coronavirus spike protein fragment containing neutralizing epitope against infectious challenge'''" is accepted for publication in ''Veterinary Immunology and Immunopathology''. (02/08/13) | *"'''A DNA prime-protein boost vaccination strategy targeting turkey coronavirus spike protein fragment containing neutralizing epitope against infectious challenge'''" is accepted for publication in ''Veterinary Immunology and Immunopathology''. (02/08/13) |
Revision as of 09:16, 19 February 2013
Home ; Research ; Lab Members ; Publications ; Contact ; Internal ; Talks ;
Welcome to Xu lab!
News
Personnel
Contact information:Peisheng Xu, Ph.D. Assistant Professor of Pharmaceutics Department of Drug Discovery and Biomedical Sciences South Carolina College of Pharmacy
715 Sumter St, 609A Columbia, SC, 29208 Phone: 803-777-0075 Fax: 803-777-8356 xup@sccp.sc.edu |